EVOKE PHARMA, INC. Conversion of Stock, Amount Converted
EVOKE PHARMA, INC. reported Conversion of Stock, Amount Converted of $18.23 million for the 86-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2015-03-04
- EVOKE PHARMA, INC. conversion of stock, amount converted for fiscal 2013 was $18.23M.
| Period end | Conversion of Stock, Amount Converted 12 month | Conversion of Stock, Amount Converted 83 month | Conversion of Stock, Amount Converted 86 month |
|---|---|---|---|
| 2014-03-31 | $18.23M 10-Q · filed 2014-05-13 | ||
| 2013-12-31 | $18.23M 10-K · filed 2015-03-04 | $18.23M 10-K · filed 2014-03-25 |